Yang J, Yu YL, Jin Y, Zhang Y, Zheng CQ. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis. World J Gastroenterol 2016; 22(33): 7579-7586
Corresponding Author of This Article
Dr. Chang-Qing Zheng, Professor, Division II, Department of Gastroenterology, Shengjing Hospital, China Medical University, No. 39 Huangxiang Road, Tiexi District, Shenyang 110024, Liaoning Province, China. firstname.lastname@example.org
Checklist of Responsibilities for the Scientific Editor of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
aP < 0.05 vs the PBC group. Since the number of cases with ANA at a titer of 1:10000 was 0 in the hepatocellular type DILI, cholestatic type DILI, and mixed type DILI groups, comparisons between them cannot be done. DILI: Drug-induced liver injury; PBC: Primary biliary cirrhosis.
Citation: Yang J, Yu YL, Jin Y, Zhang Y, Zheng CQ. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis. World J Gastroenterol 2016; 22(33): 7579-7586